Cell Line : HEC-265
Cellosaurus Index : CVCL_2928
Cellosaurus ID : HEC-265
CCLE Name
: HEC265_ENDOMETRIUM
CTRP1 Name
, CTRP2 Name
: HEC265
Cancer Type : endometrium
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| HEC-265 | (-)-gallocatechin-3-monogallate | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 2-bromopyruvate | CTRP1 | 0.2603 | 37.0000 |
|
| HEC-265 | 2-deoxyglucose | CTRP1 | 0.2890 | 37.0080 |
|
| HEC-265 | 2-fluoropalmitic acid | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 3-chloro-L-alanine | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | 4-IPP | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 4-methylfasudil | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 5-benzyl-9-tert-butyl-paullone | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 6-diazo-5-oxo-L-norleucine | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 6-NBDG | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 7-nitroindazole | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | AA-COCF3 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HEC-265 | ABH | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | ABT-751 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ABT737 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | AGK-2 | CTRP2,CTRP1 | 0.0041 | 33.3330 |
|
| HEC-265 | Alda-1 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | alpha-cyano-4-hydroxycinnamic acid | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | AM-580 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HEC-265 | ASN 05257430 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | aspirin | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | austocystin D | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | avrainvillamide | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| HEC-265 | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-265 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | batimastat | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Bax channel blocker | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BEC | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HEC-265 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-265 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | bistramide A | CTRP1 | 0.2517 | 32.2330 |
|
| HEC-265 | BIX-01294 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | BIX-01338 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | blebbistatin | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BMS-191011 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BMS-536924 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | BMS-641988 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | Bortezomib | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| HEC-265 | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | bovinocidin | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| HEC-265 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| HEC-265 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| HEC-265 | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K58730230 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| HEC-265 | BRD-K75293299 | CTRP2 | 0.0020 | 33.0000 |
|
| HEC-265 | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| HEC-265 | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD1812 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-265 | BRD2649 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| HEC-265 | BRD4770 | CTRP2 | 0.0010 | 17.0000 |
|
| HEC-265 | BRD55319 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | BRD63610 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BRD6368 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | BRD7137 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | BRD8958 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HEC-265 | BRD9786 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-265 | brefeldin A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Cabozantinib | CTRP2 | 0.0020 | 4.2000 |
|
| HEC-265 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | capsaicin | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| HEC-265 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | CAY10594 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HEC-265 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | CD-1530 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| HEC-265 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HEC-265 | CHEMBL374350 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | CHEMBL399379 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| HEC-265 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-265 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| HEC-265 | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HEC-265 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| HEC-265 | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| HEC-265 | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| HEC-265 | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| HEC-265 | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| HEC-265 | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-265 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Compound 10b | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Compound 110 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Compound 12 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Compound 2 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | Compound 4 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Compound 44 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Compound 7d-cis | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | Crizotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-265 | cyanoquinoline 11 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-265 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | cytosporone B | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | dalcetrapib | CTRP1 | 0.2587 | 33.1000 |
|
| HEC-265 | Daporinad | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | DG-041 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | dichloroacetic acid | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | DL-TBOA | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | eflornithine | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| HEC-265 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Entinostat | CTRP2 | 0.0160 | 66.0000 |
|
| HEC-265 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | ethylidene glucose | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| HEC-265 | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| HEC-265 | fatostatin | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Fedratinib | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | fingolimod | CTRP2 | 0.0041 | 66.0000 |
|
| HEC-265 | fluoropyruvate | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-265 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | FMK-PA | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | fosfomycin | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-265 | Fulvestrant | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | fumagillol | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| HEC-265 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Gemcitabine | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HEC-265 | glibenclamide | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Gly-Gly-PALO | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | GMX-1778 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | gossypol | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | GW-405833 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | GW843682X | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | idarubicin | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| HEC-265 | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Irinotecan | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | iso-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | isoliquiritigenin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | itraconazole | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0081 | 66.0000 |
|
| HEC-265 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | JZL-184 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | kinetin riboside | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Ko-143 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | L-685458 | CTRP2,CTRP1,CCLE | 0.0011 | 37.0000 |
|
| HEC-265 | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | LDN-193189 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | LE-135 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Lenalidomide | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | leucascandrolide A | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | lonidamine | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | losartan | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | LY-2365109 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | m-3M3-FBS | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | maraviroc | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Masitinib | CTRP2 | 0.0020 | 33.0000 |
|
| HEC-265 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | MK-1775 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | MK-591 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ML006 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HEC-265 | ML007 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | ML013 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HEC-265 | ML037 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ML038 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ML039 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ML050 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HEC-265 | ML101 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | ML203 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| HEC-265 | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | N-oxalyl-D-phenylalanine | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | N5-iminoethyl-L-ornithine | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | nakiterpiosin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | Navitoclax | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-265 | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HEC-265 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | neopeltolide | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | nifedipine | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Nilotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| HEC-265 | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HEC-265 | NSC23766 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | NSC632839 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | NSC95397 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Nutlin-3a | CTRP2,CTRP1,CCLE | 0.0025 | 150.0000 |
|
| HEC-265 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | NVP-AUY922 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Olaparib | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| HEC-265 | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | orteronel | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | OSW-1 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-265 | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | oxythiamine | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | P-0850 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | PAC-1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | Palbociclib | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | panduratin A | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Parthenolide | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HEC-265 | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Pemetrexed | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Pevonedistat | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | PF-3845 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | PF-750 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HEC-265 | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | phloretin | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| HEC-265 | PI-103 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | PIK-75 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Piperlongumine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 4.2000 |
|
| HEC-265 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | pluripotin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| HEC-265 | PP-30 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | PRIMA-1 | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| HEC-265 | PRIMA-1MET | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | PRL-3 Inhibitor I | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | PT-630 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | purmorphamine | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| HEC-265 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | quinoclamine | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | racemic-2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | Rapamycin | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HEC-265 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | RepSox | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | RG-108 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HEC-265 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | Ro-28-1675 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | rosiglitazone | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | rotenone | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| HEC-265 | Selumetinib | CTRP2,CCLE | 0.0025 | 270.0000 |
|
| HEC-265 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-265 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-265 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-265 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-265 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| HEC-265 | Serdemetan | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| HEC-265 | sildenafil | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HEC-265 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | simvastatin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HEC-265 | SKI-II | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HEC-265 | SN-38 | CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| HEC-265 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | SNX-2112 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-265 | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | sparfosic acid | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Staurosporine | CTRP2 | 0.0001 | 3.3000 |
|
| HEC-265 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | T-5345967 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HEC-265 | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| HEC-265 | tamatinib | CTRP2 | 0.0010 | 17.0000 |
|
| HEC-265 | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| HEC-265 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Tanespimycin | CTRP2,CTRP1,CCLE | 0.0010 | 37.0000 |
|
| HEC-265 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-265 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | Telomerase Inhibitor IX | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HEC-265 | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | TGX-115 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | tipifarnib-P2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | Tivozanib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HEC-265 | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-265 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-265 | Tozasertib | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Tretinoin | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| HEC-265 | triacsin C | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | triptolide | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | ubistatin B | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | valdecoxib | CTRP2,CTRP1 | 0.0180 | 600.0000 |
|
| HEC-265 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HEC-265 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-265 | Vismodegib | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | Vorinostat | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HEC-265 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | WT-161 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | XAV939 | CTRP1 | 0.2890 | 37.0000 |
|
| HEC-265 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-265 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-265 | YM-022 | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| HEC-265 | zebularine | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| HEC-265 | zileuton | CTRP1 | 0.2603 | 33.3330 |
|
| HEC-265 | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC